Morgan Stanley Maintains P10 Inc(PX.US) With Hold Rating, Raises Target Price to $12
P10 Is Maintained at Overweight by Barclays
P10 Analyst Ratings
Barclays Maintains P10 Inc(PX.US) With Buy Rating, Raises Target Price to $12
Oppenheimer Maintains P10 Inc(PX.US) With Buy Rating, Maintains Target Price $13
Barclays Maintains P10 Inc(PX.US) With Buy Rating, Maintains Target Price $11
Barclays Maintains P10 Inc(PX.US) With Buy Rating, Maintains Target Price $11
P10 Analyst Ratings
UBS Downgrades P10 to Neutral, Raises Price Target to $10.5
UBS Downgrades P10 Inc(PX.US) to Hold Rating, Raises Target Price to $10.5
P10 Analyst Ratings
Morgan Stanley Maintains P10 Inc(PX.US) With Hold Rating, Raises Target Price to $10
J.P. Morgan Maintains P10 Inc(PX.US) With Hold Rating, Raises Target Price to $11
P10 Analyst Ratings
Barclays Maintains Overweight on P10, Raises Price Target to $11
P10 Analyst Ratings
Keefe, Bruyette & Woods Reiterates Market Perform on P10, Raises Price Target to $9.5
Oppenheimer Adjusts Price Target on P10 to $13 From $12, Maintains Outperform Rating
Oppenheimer Adjusts P10 Price Target to $12 From $11, Maintains Outperform Rating
Oppenheimer Adjusts P10 Price Target to $11 From $17, Maintains Outperform Rating